How are OPCH strangle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the OPCH strangle priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 33.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$155.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a OPCH strangle?

The breakeven for the OPCH strangle priced on this page is roughly $20.95 and $26.55 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The OPCH market-implied 1-standard-deviation expected move in the same options snapshot is approximately 9.60%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current OPCH implied volatility affect this strangle?

OPCH ATM IV is at 33.50% with IV rank near 9.03%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

OPCH Strangle Strategy

OPCH (Option Care Health, Inc.), in the Healthcare sector, (Medical - Care Facilities industry), listed on NASDAQ.

Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care.

OPCH (Option Care Health, Inc.) trades in the Healthcare sector, specifically Medical - Care Facilities, with a market capitalization of approximately $3.57B, a trailing P/E of 17.61, a beta of 0.61 versus the broader market, a 52-week range of 18.01-36.8, average daily share volume of 3.1M, a public-listing history dating back to 1996, approximately 7K full-time employees. These structural characteristics shape how OPCH stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.61 indicates OPCH has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a strangle on OPCH?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

OPCH snapshot

As of August 14, 2026, spot at $24.03, ATM IV 33.50%, IV rank 9.03%, expected move 9.60%. The strangle on OPCH below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.

Why this strangle structure on OPCH specifically: OPCH IV at 33.50% is on the cheap side of its 1-year range, which favors premium-buying structures like a OPCH strangle, with a market-implied 1-standard-deviation move of approximately 9.60% (roughly $2.31 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated OPCH expiries trade a higher absolute premium for lower per-day decay. Position sizing on OPCH should anchor to the underlying notional of $24.03 per share and to the trader's directional view on OPCH stock.

OPCH strangle setup

The OPCH strangle below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With OPCH at $24.03 on that close, the first option leg uses a $25.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed OPCH chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 OPCH shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$25.00	$0.90
Buy 1	Put	$22.50	$0.65

OPCH strangle risk and reward

Net Premium / Debit: -$155.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$155.00
Breakeven(s): $20.95, $26.55
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

OPCH strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on OPCH. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$2,094.00
$5.32	-77.9%	+$1,562.79
$10.63	-55.7%	+$1,031.59
$15.95	-33.6%	+$500.38
$21.26	-11.5%	-$30.82
$26.57	+10.6%	+$2.03
$31.88	+32.7%	+$533.24
$37.19	+54.8%	+$1,064.44
$42.51	+76.9%	+$1,595.65
$47.82	+99.0%	+$2,126.85

When traders use strangle on OPCH

Strangles on OPCH are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the OPCH chain.

OPCH thesis for this strangle

The market-implied 1-standard-deviation range for OPCH extends from approximately $21.72 on the downside to $26.34 on the upside. A OPCH long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current OPCH IV rank near 9.03% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on OPCH at 33.50%. As a Healthcare name, OPCH options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to OPCH-specific events.

OPCH strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. OPCH positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move OPCH alongside the broader basket even when OPCH-specific fundamentals are unchanged. Always rebuild the position from current OPCH chain quotes before placing a trade.

Frequently asked questions

What is a strangle on OPCH?: A strangle on OPCH is the strangle strategy applied to OPCH (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With OPCH stock at $24.03 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed OPCH chain strike and the premiums come straight from that session's bid/ask midpoint.
How are OPCH strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the OPCH strangle priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 33.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$155.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a OPCH strangle?: The breakeven for the OPCH strangle priced on this page is roughly $20.95 and $26.55 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The OPCH market-implied 1-standard-deviation expected move in the same options snapshot is approximately 9.60%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on OPCH?: Strangles on OPCH are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the OPCH chain.
How does current OPCH implied volatility affect this strangle?: OPCH ATM IV is at 33.50% with IV rank near 9.03%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.